August 6, 2024 08:00 AM EDT
Financing
Startups

Ex­clu­sive: TCG, DCVC and Lux back new au­toim­mune biotech from Kally­ope co-founder

Kyle LaHucik

Senior Reporter

A stealth biotech from re­peat col­lab­o­ra­tors has as­sem­bled the lat­est in­dus­try megaround.

New York-based NI­LO Ther­a­peu­tics has put to­geth­er a $101 mil­lion Se­ries A, Tim …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times